VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $8,433,000 | +43.4% | 362,886 | -1.7% | 0.00% | 0.0% |
Q1 2018 | $5,879,000 | -21.4% | 369,330 | +2.6% | 0.00% | 0.0% |
Q4 2017 | $7,479,000 | +48.2% | 359,894 | +2.2% | 0.00% | +100.0% |
Q3 2017 | $5,047,000 | -16.3% | 352,211 | +1.0% | 0.00% | -50.0% |
Q2 2017 | $6,032,000 | +34.2% | 348,751 | -14.4% | 0.00% | +100.0% |
Q1 2017 | $4,494,000 | -22.3% | 407,421 | +2.2% | 0.00% | -50.0% |
Q4 2016 | $5,785,000 | -42.3% | 398,477 | -2.4% | 0.00% | -33.3% |
Q3 2016 | $10,026,000 | +41.4% | 408,406 | +16.0% | 0.00% | +50.0% |
Q2 2016 | $7,093,000 | -27.2% | 352,168 | -4.9% | 0.00% | -33.3% |
Q1 2016 | $9,738,000 | -74.4% | 370,253 | -0.9% | 0.00% | -72.7% |
Q4 2015 | $37,990,000 | -20.9% | 373,748 | +3.6% | 0.01% | -26.7% |
Q3 2015 | $48,018,000 | -39.7% | 360,908 | +0.6% | 0.02% | -31.8% |
Q2 2015 | $79,674,000 | -3.4% | 358,652 | -13.6% | 0.02% | +4.8% |
Q1 2015 | $82,461,000 | +35.5% | 415,174 | -2.4% | 0.02% | +31.2% |
Q4 2014 | $60,872,000 | +6.3% | 425,360 | -2.5% | 0.02% | 0.0% |
Q3 2014 | $57,267,000 | +16.8% | 436,476 | +17.3% | 0.02% | +23.1% |
Q1 2014 | $49,047,000 | +10.3% | 372,057 | -1.7% | 0.01% | +8.3% |
Q4 2013 | $44,456,000 | -42.9% | 378,678 | -49.3% | 0.01% | 0.0% |
Q3 2013 | $77,914,000 | +155.9% | 746,808 | +111.2% | 0.01% | +20.0% |
Q2 2013 | $30,443,000 | +1522050.0% | 353,670 | +1768250.0% | 0.01% | – |
Q1 2013 | $2,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |